鞘内药物输注系统移除后持续性脊柱头痛：一例报告及文献综述
Persistent Spinal Headache After Removal of Intrathecal Drug Delivery System: A Case Report and Review of Literature.
作者信息
Kurnutala Lakshmi N, Kim David, Sayeed Huma, Sibai Nabil
机构信息
Department of Anesthesiology, University of Mississippi Medical Center, Jackson, Mississippi, USA.
Department of Anesthesiology and Pain Medicine, Henry Ford Hospital, Detroit, Michigan, USA.
出版信息
Anesth Pain Med. 2015 Oct 10;5(5):e29786. doi: 10.5812/aapm.29786. eCollection 2015 Oct.
INTRODUCTION
To report and discuss the spinal headache following insertion and removal of intrathecal drug delivery system in patients with chronic pain disorders.
CASE PRESENTATION
Intrathecal drug delivery system (IDDS) was initially used for the management of chronic malignant pain; it has since been used to manage pain from other nonmalignant conditions as well. Spinal headache is one of the complications during the trial, permanent placement and after removal of intrathecal drug delivery catheter systems. A 48-year-male patient with chronic pain disorder developed a refractory spinal headache after removing the intrathecal drug delivery system requiring a surgical intervention to resolve the problem.
CONCLUSIONS
Conservative management is successful in the vast majority of patients with spinal headache. Interventional procedures are required in a small fraction of patients for symptomatic relief.
引言
报告并讨论慢性疼痛疾病患者鞘内药物输送系统置入和取出后发生的脊柱头痛。
病例介绍
鞘内药物输送系统（IDDS）最初用于治疗慢性恶性疼痛；此后也被用于治疗其他非恶性疾病引起的疼痛。脊柱头痛是鞘内药物输送导管系统试验、永久置入及取出过程中的并发症之一。一名48岁慢性疼痛疾病男性患者在取出鞘内药物输送系统后出现难治性脊柱头痛，需要手术干预来解决问题。
结论
绝大多数脊柱头痛患者采用保守治疗成功。一小部分患者需要介入治疗来缓解症状。
Zotero 插件